Enhancing anti-tumour efficacy with immunotherapy combinations

Review outlines rationale for treatment, including combinations with chemotherapy, targeted therapy, radiation therapy, intratumoural therapies, immunomodulators, and adaptive cell therapy and provides an assessment to identify who will benefit from monotherapy vs combinations.

Source:

The Lancet